Fred Alger Management, LLC Relay Therapeutics, Inc. Transaction History

Fred Alger Management, LLC

  • $20.1 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$20.26 - $32.36 $3.6 Million - $5.75 Million
-177,771 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$26.0 - $37.03 $2.18 Million - $3.1 Million
83,833 Added 89.24%
177,771 $5.46 Million
Q3 2021

Nov 15, 2021
BUY
$29.75 - $37.99 $2.79 Million - $3.57 Million
93,938 New
93,938 $2.96 Million

Others Institutions Holding RLAY

# of Institutions
183
Shares Held
127M
Call Options Held
1.7K
Put Options Held
18K
View Full List

About Relay Therapeutics, Inc.

RLAY Quotes by TradingView
  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $780M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email